Rankings
▼
Calendar
IRWD Q4 2016 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IRWD
Ironwood Pharmaceuticals, Inc.
$603M
Q4 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$87M
Gross Profit
$86M
97.9% margin
Operating Income
-$6M
-7.2% margin
Net Income
-$14M
-15.4% margin
EPS (Diluted)
$-0.09
QoQ Revenue Growth
+32.3%
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$20M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$710M
Total Liabilities
$643M
Stockholders' Equity
$67M
Cash & Equivalents
$54M
← FY 2016
All Quarters
Q1 2017 →
